Welcome to Ningbo Zhongyuan Biotechnology Co., Ltd./Welcome to Guizhou Zhongyuan Biotechnology Co., Ltd.
Home
Products
Luminous Series
Flow cytometry
Immune Series
Molecular Series
Other Series
Solution
Tumor immunotherapy
Health Management
Early tumor screening
Inflammation series detection
Immunity assessment
Platelet function
Sperm function assessment
Technology
Immunomagnetic particle luminescence platform
Flow Cytometry Platform
Molecular and other technology platforms
Human
Talent pool
Recruitment post
Service
Equipment maintenance
Reagent Related
Message board
News
Development process
Important events
Industry Information
Contact
Ningbo Zhongyuan Biotechnology
Guizhou Zhongyuan Medical Technology
Guizhou Zhongyuan Biotechnology
中
News center
History
Events
Industry news
2023/10/24
How can you score your immunity? Scientists Introduce Assessment Criteria
According to a report on the website of the British "New Scientist" weekly on January 31, when you cover your quilt and wipe your nose because of the third cold this year, you may wonder if your immune system is working. This is the question we all want to know: Is our immune system healthy? Now, an emerging field of immunology tries to answer this question by "scoring" your immune system. The aim is to help people prepare for a rainy day, prompting them to change their lifestyle and avoid getting sick.
View Details
2023/09/25
Collaborate with tumor initiating cell research and treatment institutions in the United States and other countries
OntaGen Biotech Canada. OntaGen provides specific tumor early diagnosis, tumor immunotherapy and tumor personalized treatment technology worldwide. As a OntaGen Chinese partner, Zhongyuan has introduced technologies such as cryobiological freezing technology, specific tumor early diagnosis technology and tumor cell immunotherapy.